Tauns Laboratories Inc
TSE:197A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tauns Laboratories Inc
TSE:197A
|
JP |
|
D
|
DigiPlus Interactive Corp
XPHS:PLUS
|
PH |
|
Vemanti Group Inc
OTC:VMNT
|
US |
|
A
|
A-1 Acid Ltd
BSE:542012
|
IN |
|
M
|
MTR Corp Ltd
XMUN:MRI
|
HK |
Intrinsic Value
Is 197A undervalued or overvalued?
See the intrinsic value estimate for Tauns Laboratories Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
197A looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 197A’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Tauns Laboratories Does
Tauns Laboratories makes and sells medicines, with a strong focus on stomach and digestive health products. It develops its own branded drugs and health-related products, and it also sells them through pharmacies, drugstores, and medical channels. For investors, the key point is that this is a product business tied to everyday healthcare needs rather than a software or services model.
- Headquarters
- Japan JP
- Employees
- 316
- IPO date
- Jun 20, 2024
Earnings Waterfall
Tauns Laboratories Inc
The intrinsic value for Tauns Laboratories Inc (197A) under the Base Case is hidden JPY.
Compared with the current market price of 499 JPY, the stock appears hidden.